Poland· PL-100104050
Locatop
A desonide product containing desonidum, registered in Poland by Pierre Fabre Medicament. The same ATC class is registered in 5 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Desonide is registered in 5 of 19 countries.
Countries holding a registration under ATC D07AB08 (desonide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Desonide · ATC D07AB08
5 / 19 countries
- Canada
- Finlandprice
- Norwayprice
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Desonidum
- Manufacturer
- Pierre Fabre Medicament
- Country
- Poland (PL)
- ATC code
- D07AB08
- ATC class
- Desonide
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990897810
- gtin05909990897827
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
55 interactions on record for desonide.
Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Desonide · interactions on record
55 records
Same medicine, other countries
Desonide in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDesonideNORTHSTAR RX LLC
- FinlandApolarTeva B.V.
- NorwayApolarTeva B.V.
- FranceLOCAPRED 0,1 %, crèmePIERRE FABRE MEDICAMENT
- CanadaPDP-DESONIDEPENDOPHARM DIVISION OF PHARMASCIENCE INC
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Finland · Apolar
- France · Desowen, Locapred
- Norway · Apolar
- Portugal · Zotinar, Zotinar Capilar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f119fa3d-26ad-4138-b22e-55acf9e3d405 GET /v1/drugs/f119fa3d-26ad-4138-b22e-55acf9e3d405?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krem",
"source": "urpl",
"strength": "1 mg/ml",
"packaging": "05909990897810 ¦ Rp ¦ Skasowane ¦ 17954\n1 tuba 15 g\n05909990897827 ¦ Rp ¦ 17955\n1 tuba 30 g",
"substance": "Desonidum 0,1 g/30 g",
"common_name": "Desonidum",
"pl_product_id": "100104050",
"pozwolenie_nr": "08978",
"auth_procedure": "NAR",
"authorisation_validity": "2025-11-13"
}See everything about desonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.